PhilipPConnellMD

Associate Professor of Radiation and Cellular Oncology, University of Chicago Medicine

Dr. Connell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
5841 S Maryland Ave
Chicago, IL 60637
Phone+1 888-824-0200

Fax+1 773-834-7340

University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 1996 - 2000
Westchester Medical CenterInternship, Internal Medicine, 1995 - 1996
New York Medical CollegeClass of 1995

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

PubMed

47 citations
The significance of adnexal involvement in endometrial carcinoma.
Philip P. Connell, Jacob Rotmensch, Steven E Waggoner, Arno J. Mundt
Gynecologic Oncology. 1999-07-01
52 citations
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer.
Stanley I. Gutiontov, William Tyler Turchan, Liam F. Spurr, Sherin J. Rouhani, Carolina Soto Chervin
Scientific Reports. 2021-10-08
134 citations
RI-1: A chemical inhibitor of RAD51 that disrupts Homologous recombination in human cells
Brian Budke, Hillary L. Logan, Jay H. Kalin, Anna Zelivianskaia, William Cameron McGuire
Nucleic Acids Research. 2012-08-01

RAD51 Inhibitors For Chemotherapy And Radiation TherapyNational Cancer Institute2010–2012
Inhibition Of Recombination DNA Repair In Pancreatic Cancer CellsNational Cancer Institute2007–2008